Asia · Markets & Finance · CNBC-TV18

Natco Pharma launches Carboplatin injection in US market; shares rise 2%

Published by CNBC-TV18 · India 1 h ago

According to industry sales data, Carboplatin Injection generated projected revenues of $27.8 million within the United States for the twelve months concluding in June 2026.

Read the full article on CNBC-TV18 Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

The Economic Times

Zepto faces an expired besan complaint

Mint

Stock market holiday tomorrow on Dussehra: Are BSE, NSE open or closed for trading on Tuesday 20 Oct? Check calendar

The Straits Times Business

VietJet hit with global asset freeze in dispute with London investment firm FitzWalter

The Business Times

Iras unveils new digital tools for easier corporate income tax filing

Pulse (Maeil Business)

Samsung, SK hynix lose ground amid AI investment concerns

The Edge Singapore